Weekly Recap: BASF €10.3bn bid rejected and NRW backs Evonik jobs&independence
Evonik Industries AG (EVK) rejected BASF's €10.3bn takeover bid, calling it undervalued. North Rhine-Westphalia, linked to Evonik's largest shareholder, demanded job and independence protections in any deal.
How this was made
The 30-second read
Why it matters
The failed deal removes a potential premium for Evonik and may dampen BASF's strategic outlook.
Market read
Primary M&A news with significant valuation impact for both parties.
What to watch
Regulatory scrutiny or political pressure in North Rhine-Westphalia may have influenced the decision.
Background
The article reports the first public disclosure of Evonik's rejection of BASF's takeover bid.
Market effects
German chemicals sector may see heightened scrutiny of M&A activity.
European markets could react to the stalled consolidation in chemicals.
Limited to chemicals sector; no broad market impact.
Counterpoint
The rejection could be a catalyst for Evonik to pursue independent growth, potentially boosting its stock.
Key entities
- companyEvonik Industries AG
German chemicals producer that rejected the bid.
- companyBASF SE
German chemicals giant that made the €10.3bn offer.
